{
    "Trade/Device Name(s)": [
        "iHealth BG5 Wireless Smart Gluco-Monitoring System",
        "iHealth BG5L Wireless Smart Gluco-Monitoring System"
    ],
    "Submitter Information": "Andon Medical Co., Ltd.",
    "510(k) Number": "K123935",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120813",
        "K110017"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP",
        "JJX"
    ],
    "Summary Letter Date": "April 12, 2013",
    "Summary Letter Received Date": "March 12, 2013",
    "Submission Date": "December 14, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.2100",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth BG5 Wireless Smart Gluco-Monitoring System",
        "iHealth BG5L Wireless Smart Gluco-Monitoring System",
        "iHealth Gluco-Smart App"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test strip",
        "Control solution",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth BG5 and BG5L wireless smart gluco-monitoring systems for self-testing blood glucose using electrochemical biosensor technology with Bluetooth connectivity to iOS devices.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from various body sites for self-testing by people with diabetes at home to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}